US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.6025

+0.05259.55%

Post-market: 0.5880-0.0145-2.41%19:59 EDT

Volume:2.46M

Turnover:1.41M

Market Cap:14.15M

PE:-0.88

High:0.6320

Open:0.5500

Low:0.5192

Close:0.5500

Loading ...

Overview Company News Filings

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

Acurx Announces Publication of Positive Results From an in-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of Cdi

THOMSON REUTERS

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares

MT Newswires Live

H.C. Wainwright Reaffirms Their Buy Rating on Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

BRIEF-Acurx Pharmaceuticals Announces $2.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours

MT Newswires Live

Acurx to sell 2.46M shares at $1.015 in registered direct offering

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BRIEF-Acurx Receives Positive Regulatory Guidance From EMA For Ibezapolstat Phase 3 Program For CDI

Acurx Receives Positive Regulatory Guidance From Ema for Ibezapolstat Phase 3 Program for C. Difficile Infection (Cdi)

THOMSON REUTERS

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACXP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":0.6025,"timestamp":1750708800000,"preClose":0.55,"halted":0,"volume":2456933,"hourTrading":{"tag":"盘后","latestPrice":0.588,"preClose":0.6025,"latestTime":"19:59 EDT","volume":89784,"amount":52344.2027,"timestamp":1750723176697},"delay":0,"floatShares":20909500,"shares":23481606,"eps":-0.686187,"marketStatus":"Not Yet Opened","change":0.0525,"latestTime":"06-23 16:00:00 EDT","open":0.55,"high":0.632,"low":0.5192,"amount":1409360.4033647,"amplitude":0.205091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.686187,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750752000000},"marketStatusCode":0,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":0.55,"preHourTrading":{"tag":"盘前","latestPrice":0.531,"preClose":0.55,"latestTime":"09:29 EDT","volume":93265,"amount":49930.415685500004,"timestamp":1750685395608},"postHourTrading":{"tag":"盘后","latestPrice":0.588,"preClose":0.6025,"latestTime":"19:59 EDT","volume":89784,"amount":52344.2027,"timestamp":1750723176697},"volumeRatio":0.034096,"impliedVol":0.4811,"impliedVolPercentile":0.196},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","floatShares":20909500,"roa":"-106.67%","roe":"-285.79%","lyrEps":-0.872535,"volumeRatio":0.034096,"shares":23481606,"dividePrice":0,"high":0.632,"amplitude":0.205091,"preClose":0.55,"low":0.5192,"week52Low":0.3,"pbRate":"6.12","week52High":3.325,"institutionHeld":0,"latestPrice":0.6025,"eps":-0.686187,"divideRate":0,"volume":2456933,"delay":0,"ttmEps":-0.686187,"open":0.55,"prevYearClose":0.814,"prevWeekClose":0.55,"prevMonthClose":0.3886,"prevQuarterClose":0.39,"fiveDayClose":0.305,"twentyDayClose":0.3982,"sixtyDayClose":0.435},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACXP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516635992","title":"Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635992","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635992?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat  to other anti-CDI antibiotics in a germ-free mouse model. Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced compared to those observed in vancomycin -or metronidazole -treated groups, complementing prior Phase 2 clinical findings showing IBZ's more selective antibacterial activity. Notable differences were observed between the microbiome of IBZ- and fidaxomicin -treated groups, which may allow for differentiation of these two anti-CDI antibiotics in future studies. Results establish IBZ differentiating effects on the gut microbiome, indicating a more selective spectrum of microbiome alteration compared to broader-spectrum antibiotics like VAN and MET and a narrower spectrum of microbiome alteration compared to FDX. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-nonclinical-vivo-130000861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDSA","BK4131","LU0310800965.SGD","BK4194","LU1989771016.USD","MET","BK4533","BK4139","BK4135","LU1989772840.SGD","LU1291159041.SGD","MAA","BK4563","ACXP","BK4162","PK","BK4215","LU0048573561.USD","BK4585","LU1989772923.USD","LU0251142724.SGD","LU0742534661.SGD","ECC","LU0052756011.USD","LU1267930227.SGD","VRE","LU0128525689.USD","BK4588","BK4202","LU1571399168.USD","BK4539","NCI","GAIN","LU0251131958.USD","LU1496350502.SGD","FDX","BK4218","BK4181"],"gpt_icon":0},{"id":"2514321656","title":"Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321656","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321656?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","GAIN","BK4194","BK4588","VRE","BK4539","BK4585","MAA","BK4139","BK4563","BK4215","ACXP"],"gpt_icon":0},{"id":"2513250047","title":"Acurx Announces Publication of Positive Results From an in-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of Cdi","url":"https://stock-news.laohu8.com/highlight/detail?id=2513250047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513250047?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402032,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUAC542FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ACXP","BK4563"],"gpt_icon":0},{"id":"2513726852","title":"Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726852","media":"CNW Group","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726852?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"Major finding provides mechanistic explanation for ibezapolstat's  selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of the Bacillota phylum, including C. difficile, while certain beneficial taxa are naturally resistant to IBZ, allowing regrowth of resistant microbes known to confer health benefits. This study used in silico methods to better interpret the narrower than expected ibezapolstat  spectrum of activity observed in human trials, which included increased proportion of certain key gut microbiota of the Bacillota phylum. IBZ susceptibility of human commensal  microbiota was predicted using genomic analysis and a phylogenetic tree construction of the IBZ target enzyme, pol IIIC. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP and Fast-Track Designation and has received SME  designation by the EMA. Acurx's Executive Ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-positive-results-130000638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAA","GAIN","BK4215","BK4585","PK","BK4139","ACXP","BK4218","VRE","BK4181","IDSA","BK4563","ECC","BK4135","BK4588","BK4194","BK4539"],"gpt_icon":0},{"id":"2512230104","title":"Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2512230104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512230104?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:05","pubTimestamp":1739970352,"startTime":"0","endTime":"0","summary":"Acurx (ACXP) Pharmaceuticals announced that a new patent has been granted by the Japanese Patent Office, JPO, in January 2025. This patent relates ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acurx-new-patent-granted-by-jpo-related-to-dna-polymerase-iiic-inhibitors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acurx-new-patent-granted-by-jpo-related-to-dna-polymerase-iiic-inhibitors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNA","ACXP","BK4139","BK4109","BK4563","BK4539"],"gpt_icon":0},{"id":"2512104227","title":"JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2512104227","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512104227?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., Feb. 19, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new patent has been granted by the Japanese Patent Office  in January 2025. This patent relates to DNA Polymerase IIIC Inhibitors, including compositions-of-matter, surface coatings and pharmaceutical compositions for use in methods of treatingGram-positive bacterial infection. This is the latest in the series of granted patents and pending patent applications that Acrux has filed to protect its proprietary technologies in the field of antimicrobials.To date, Acurx has obtained three U.S. patents, one Israeli patent and now one Japanese patent, in each case, which cover the ACX-375C program, relating to DNA Polymerase IIIC Inhibitors, with other country-level filings in process.The primary efficacy analysis will be performed using a Modified Intent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jpo-grants-acurx-pharmaceuticals-patent-130000150.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jpo-grants-acurx-pharmaceuticals-patent-130000150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","PK","BK4588","BK4539","BK4215","ACXP","GAIN","BK4563","DNA","MAA","IDSA","BK4218","ECC","BK4135","BK4194","VRE","BK4585","BK4139","BK4181"],"gpt_icon":0},{"id":"2508918507","title":"Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2508918507","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508918507?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:55","pubTimestamp":1738360551,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals  said Friday in a regulatory filing some selling shareholders may sell up to about 2.6 million shares.The number of shares comprises up to about 2.46 million shares issuable upon exercise of Series E warrants acquired by some of the shareholders under a purchase agreement with an exercise price of $0.90 per share and up to 147,783 shares issuable upon exercise of placement agent warrants, the company said.The selling shareholders will get all of the proceeds from any sales of the shares, Acurx said.Acurx shares rose 3.3% in after-hours trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACXP","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"2503580584","title":"H.C. Wainwright Reaffirms Their Buy Rating on Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503580584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503580584?lang=en_us&edition=fundamental","pubTime":"2025-01-13 23:35","pubTimestamp":1736782548,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ed Arce reiterated a Buy rating on Acurx Pharmaceuticals (ACXP – Research Report) today and set a price target of $12.00. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-acurx-pharmaceuticals-acxp-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-acurx-pharmaceuticals-acxp-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACXP"],"gpt_icon":0},{"id":"2502818953","title":"Acurx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2502818953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502818953?lang=en_us&edition=fundamental","pubTime":"2025-01-11 02:02","pubTimestamp":1736532120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACXP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 10, 2025 13:02 ET (18:02 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2501755555","title":"Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501755555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501755555?lang=en_us&edition=fundamental","pubTime":"2025-01-08 06:00","pubTimestamp":1736287203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA71N80T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACXP","BK4563","BK4539"],"gpt_icon":0},{"id":"2501308299","title":"BRIEF-Acurx Pharmaceuticals Announces $2.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501308299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501308299?lang=en_us&edition=fundamental","pubTime":"2025-01-07 07:01","pubTimestamp":1736204492,"startTime":"0","endTime":"0","summary":"Jan 6 (Reuters) - Acurx Pharmaceuticals Inc   :   * ACURX PHARMACEUTICALS, INC. ANNOUNCES $2.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULESSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","TSYW.SI","MNQmain","IE00BGHQF748.EUR","QID","BK4585","PSQ","BK4139","ACXP","BK4563","TQQQ","LU2210150020.SGD","NVIW.SI","BK4539","BK4588","IE00B3QW5Z07.USD","SQQQ","LU2095319765.USD","NDAQ","NQmain","BK4112",".IXIC","USJW.SI","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","QLD"],"gpt_icon":0},{"id":"2501529937","title":"Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2501529937","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501529937?lang=en_us&edition=fundamental","pubTime":"2025-01-07 07:00","pubTimestamp":1736204430,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals  said late Monday it struck a deal to sell almost 2.5 million shares at $1.015 per share in a registered direct offering to raise some $2.5 million for the late-stage biopharmaceutical company.Acurx also said it will issue warrants in a concurrent private placement to buy up to almost 2.5 million shares, with each warrant exercisable at $0.90 per share. H.C. Wainwright & Co. is the placement agent.The company expects the offering to close around Tuesday and plans to use the net proceeds for working capital and other general corporate purposes.The company's shares were down about 10% in after-hours activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","BK4139","ACXP","BK4539"],"gpt_icon":0},{"id":"2501964642","title":"Acurx to sell 2.46M shares at $1.015 in  registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2501964642","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501964642?lang=en_us&edition=fundamental","pubTime":"2025-01-07 06:40","pubTimestamp":1736203215,"startTime":"0","endTime":"0","summary":"Acurx (ACXP) Pharmaceuticals announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,463,058 share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acurx-to-sell-2-46m-shares-at-1-015-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acurx-to-sell-2-46m-shares-at-1-015-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACXP","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2501295262","title":"Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501295262","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501295262?lang=en_us&edition=fundamental","pubTime":"2025-01-07 06:35","pubTimestamp":1736202902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA5JQYN7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ACXP","BK4139","BK4563"],"gpt_icon":0},{"id":"2501398296","title":"Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501398296","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501398296?lang=en_us&edition=fundamental","pubTime":"2025-01-07 06:35","pubTimestamp":1736202900,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,463,058 shares of its common stock at a purchase price of $1.015 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 2,463,058 shares of common stock. The warrants will have an exercise price of $0.90 per share, will be exercisable upon issuance and expire five years following the date of issuance. The closing of the offering is expected to occur on or about January 7, 2025, subject to the satisfaction of customary closing conditions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","BK4139","IE00BKPKM429.USD","USJW.SI","BK4194","LU2210149790.SGD","SQQQ","IE00B3QW5Z07.USD","PSQ","ACXP","VRE","BK4563","BK4112","QLD","BK4585","LU2095319765.USD","USAW.SI","NQmain","MNQmain","QID","NVIW.SI","NDAQ",".IXIC","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","BK4539","BK4588","TQQQ"],"gpt_icon":1},{"id":"2501253806","title":"BRIEF-Acurx Receives Positive Regulatory Guidance From EMA For Ibezapolstat Phase 3 Program For CDI","url":"https://stock-news.laohu8.com/highlight/detail?id=2501253806","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501253806?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:56","pubTimestamp":1736175389,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Receives Positive Regulatory Guidance From EMA For Ibezapolstat Phase 3 Program For CDIJan 6  - Acurx Pharmaceuticals Inc ACXP.O:ACURX RECEIVES POSITIVE REGULATORY GUIDANCE FROM EMA FOR IBEZAPOLSTAT PHASE 3 PROGRAM FOR C. DIFFICILE INFECTION Source text: nPn3jr0p8aFurther company coverage: ACXP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA8JTXRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2501231013","title":"Acurx Receives Positive Regulatory Guidance From Ema for Ibezapolstat Phase 3 Program for C. Difficile Infection (Cdi)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501231013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501231013?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:30","pubTimestamp":1736170204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA8JTXRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4563","ACXP","BK4139"],"gpt_icon":0},{"id":"2501585882","title":"Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501585882","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501585882?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:30","pubTimestamp":1736170200,"startTime":"0","endTime":"0","summary":"Acurx has now received positive written responses from the EMA  under its Scientific Advice Procedure that the clinical, non-clinical and CMC  information package submitted supports advancement of the ibezapolstat Phase 3 program. The responses also included guidance on ibezapolstat's regulatory pathway for a Marketing Authorization Application for ibezapolstat in CDI. With mutually consistent feedback from both EMA and FDA, Acurx is well positioned to commence our international Phase 3 registration program. Acurx is also preparing to request regulatory guidance to initiate clinical trials in Japan, Canada and the United Kingdom. Ibezapolstat has previously been granted FDA QIDP and Fast-Track Designation from FDA and Acurx has received SME  designation by the EMA to benefit from fee incentives and other support from the EMA for EU Marketing Authorization. Acurx previously announced it had a successful End of Phase 2 Meeting achieving agreement with FDA on non-clinical and clinical Pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-receives-positive-regulatory-guidance-133000707.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-receives-positive-regulatory-guidance-133000707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4218","BK4194","GAIN","BK4563","ECC","BK4139","ACXP","PK","VRE","IDSA","BK4135","BK4181"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACXP\",params:#limit:5,,,undefined,":[{"date":"2025-05-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"defaultRemindTime":1747123200000,"name":null,"time":"Pre-Market","dateTimestamp":1747108800000,"actualEps":null},{"market":"US","date":"2025-03-18","symbol":"ACXP","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.38},{"date":"2024-11-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"defaultRemindTime":1731488400000,"name":null,"time":"Pre-Market","dateTimestamp":1731474000000,"actualEps":null},{"market":"US","date":"2024-08-09","symbol":"ACXP","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.26},{"date":"2024-05-15","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"defaultRemindTime":1715760000000,"name":null,"time":"Pre-Market","dateTimestamp":1715745600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742529600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACXP","date":"2025-06-20","current":-1.423798,"percent":0.854855,"low":-15.698763,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"high":-0.470005,"avg":-3.215265,"sd":2.2535,"marketCap":16906756},"quantilePoints":[{"date":"2021-06-11","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-15","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-25","current":-15.698763,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":75279744},{"date":"2021-07-02","current":-12.09725,"twenty":-12.878918,"median":-11.938223,"eighty":-11.938223,"marketCap":58009530},{"date":"2021-07-09","current":-12.572868,"twenty":-12.738301,"median":-11.938223,"eighty":-11.938223,"marketCap":60290246},{"date":"2021-07-16","current":-12.469473,"twenty":-12.639041,"median":-12.076571,"eighty":-11.938223,"marketCap":59794438},{"date":"2021-07-23","current":-11.518236,"twenty":-12.560461,"median":-12.014533,"eighty":-11.866925,"marketCap":55233005},{"date":"2021-07-30","current":-11.745706,"twenty":-12.502559,"median":-11.938223,"eighty":-11.580273,"marketCap":56323783},{"date":"2021-08-06","current":-10.050023,"twenty":-12.458729,"median":-11.938223,"eighty":-11.427248,"marketCap":48192532},{"date":"2021-08-13","current":-6.159321,"twenty":-12.399613,"median":-11.893662,"eighty":-10.608357,"marketCap":48572198},{"date":"2021-08-20","current":-5.607549,"twenty":-12.287497,"median":-11.828422,"eighty":-10.06243,"marketCap":44220938},{"date":"2021-08-27","current":-6.172153,"twenty":-12.088978,"median":-11.528575,"eighty":-7.064488,"marketCap":48673390},{"date":"2021-09-03","current":-7.416849,"twenty":-12.051755,"median":-11.476878,"eighty":-6.405694,"marketCap":58489022},{"date":"2021-09-10","current":-6.41596,"twenty":-12.035212,"median":-10.897864,"eighty":-6.364632,"marketCap":50596040},{"date":"2021-09-17","current":-5.877019,"twenty":-12.014533,"median":-10.608357,"eighty":-6.364632,"marketCap":46345972},{"date":"2021-09-24","current":-5.626797,"twenty":-11.938223,"median":-10.215455,"eighty":-6.172153,"marketCap":44372727},{"date":"2021-10-01","current":-6.68543,"twenty":-11.938223,"median":-9.998325,"eighty":-6.159321,"marketCap":52721073},{"date":"2021-10-08","current":-5.248255,"twenty":-11.938223,"median":-9.863911,"eighty":-5.992506,"marketCap":41387560},{"date":"2021-10-15","current":-6.300472,"twenty":-11.938223,"median":-7.333442,"eighty":-5.979674,"marketCap":49685311},{"date":"2021-10-22","current":-6.184985,"twenty":-11.938223,"median":-6.865077,"eighty":-5.979674,"marketCap":48774582},{"date":"2021-10-29","current":-6.41596,"twenty":-11.938223,"median":-6.794501,"eighty":-5.992506,"marketCap":50596040},{"date":"2021-11-05","current":-6.852245,"twenty":-11.938223,"median":-6.865077,"eighty":-6.031002,"marketCap":54036570},{"date":"2021-11-12","current":-4.527743,"twenty":-11.849101,"median":-6.858661,"eighty":-6.031002,"marketCap":50772486},{"date":"2021-11-19","current":-4.427531,"twenty":-11.828422,"median":-6.736758,"eighty":-5.966842,"marketCap":49648749},{"date":"2021-11-26","current":-4.454861,"twenty":-11.828422,"median":-6.68543,"eighty":-5.861621,"marketCap":49955222},{"date":"2021-12-03","current":-3.780711,"twenty":-11.762249,"median":-6.614854,"eighty":-5.699938,"marketCap":42395536},{"date":"2021-12-10","current":-3.835372,"twenty":-11.580273,"median":-6.557111,"eighty":-5.569053,"marketCap":43008484},{"date":"2021-12-17","current":-4.035795,"twenty":-11.522372,"median":-6.505783,"eighty":-5.166131,"marketCap":45255958},{"date":"2021-12-23","current":-4.32732,"twenty":-11.493421,"median":-6.428792,"eighty":-4.527743,"marketCap":48525012},{"date":"2021-12-31","current":-3.936859,"twenty":-11.476878,"median":-6.41596,"eighty":-4.409311,"marketCap":44146523},{"date":"2022-01-07","current":-4.017574,"twenty":-11.439656,"median":-6.358216,"eighty":-4.32732,"marketCap":45051642},{"date":"2022-01-14","current":-4.172447,"twenty":-11.104655,"median":-6.313304,"eighty":-4.289057,"marketCap":46788327},{"date":"2022-01-21","current":-3.316093,"twenty":-10.839963,"median":-6.223481,"eighty":-4.21982,"marketCap":37185482},{"date":"2022-01-28","current":-3.534737,"twenty":-10.695209,"median":-6.172153,"eighty":-4.137828,"marketCap":39637272},{"date":"2022-02-04","current":-3.589398,"twenty":-10.608357,"median":-6.159321,"eighty":-4.074057,"marketCap":40250220},{"date":"2022-02-11","current":-3.71694,"twenty":-10.550456,"median":-6.063082,"eighty":-4.024862,"marketCap":41680431},{"date":"2022-02-18","current":-3.73516,"twenty":-10.364344,"median":-5.979674,"eighty":-3.984778,"marketCap":41884747},{"date":"2022-02-25","current":-3.252322,"twenty":-10.194776,"median":-5.966842,"eighty":-3.953804,"marketCap":36470377},{"date":"2022-03-04","current":-3.252322,"twenty":-10.099653,"median":-5.896267,"eighty":-3.859058,"marketCap":36470377},{"date":"2022-03-11","current":-3.644059,"twenty":-10.029344,"median":-5.787196,"eighty":-3.791643,"marketCap":40863168},{"date":"2022-03-18","current":-2.922007,"twenty":-9.942491,"median":-5.68454,"eighty":-3.755202,"marketCap":37248855},{"date":"2022-03-25","current":-2.838922,"twenty":-9.913541,"median":-5.607549,"eighty":-3.720584,"marketCap":36189718},{"date":"2022-04-01","current":-2.737374,"twenty":-9.379631,"median":-5.44715,"eighty":-3.682321,"marketCap":34895218},{"date":"2022-04-08","current":-2.881869,"twenty":-7.43738,"median":-5.248255,"eighty":-3.645881,"marketCap":36737195},{"date":"2022-04-14","current":-3.210996,"twenty":-7.416849,"median":-4.609734,"eighty":-3.634948,"marketCap":40932808},{"date":"2022-04-22","current":-3.210996,"twenty":-7.250034,"median":-4.504968,"eighty":-3.534737,"marketCap":40932808},{"date":"2022-04-29","current":-3.003032,"twenty":-7.237203,"median":-4.427531,"eighty":-3.388974,"marketCap":38281743},{"date":"2022-05-06","current":-3.123797,"twenty":-7.121715,"median":-4.35465,"eighty":-3.315273,"marketCap":39821223},{"date":"2022-05-13","current":-1.994712,"twenty":-7.044724,"median":-4.32732,"eighty":-3.252322,"marketCap":27813277},{"date":"2022-05-20","current":-1.943188,"twenty":-7.01906,"median":-4.318209,"eighty":-3.210996,"marketCap":27094853},{"date":"2022-05-27","current":-1.923388,"twenty":-6.993396,"median":-4.236218,"eighty":-3.146776,"marketCap":26818773},{"date":"2022-06-03","current":-1.880623,"twenty":-6.942068,"median":-4.208888,"eighty":-3.079156,"marketCap":26222481},{"date":"2022-06-10","current":-2.774931,"twenty":-6.918971,"median":-4.158782,"eighty":-3.024918,"marketCap":38692271},{"date":"2022-06-17","current":-2.679244,"twenty":-6.906139,"median":-4.117786,"eighty":-2.999671,"marketCap":37358055},{"date":"2022-06-24","current":-2.716047,"twenty":-6.880475,"median":-4.090456,"eighty":-2.939922,"marketCap":37871215},{"date":"2022-07-01","current":-2.76021,"twenty":-6.857378,"median":-4.044905,"eighty":-2.90143,"marketCap":38487007},{"date":"2022-07-08","current":-2.760137,"twenty":-6.852245,"median":-4.026684,"eighty":-2.848154,"marketCap":38485981},{"date":"2022-07-15","current":-2.668203,"twenty":-6.80605,"median":-4.008464,"eighty":-2.820986,"marketCap":37204107},{"date":"2022-07-22","current":-2.657162,"twenty":-6.72136,"median":-3.972024,"eighty":-2.802901,"marketCap":37050159},{"date":"2022-07-29","current":-2.635081,"twenty":-6.693129,"median":-3.953804,"eighty":-2.779424,"marketCap":36742263},{"date":"2022-08-05","current":-2.88534,"twenty":-6.68543,"median":-3.921918,"eighty":-2.779424,"marketCap":40231751},{"date":"2022-08-12","current":-3.956018,"twenty":-6.664899,"median":-3.844482,"eighty":-2.782292,"marketCap":49687496},{"date":"2022-08-19","current":-3.519492,"twenty":-6.618704,"median":-3.839927,"eighty":-2.785236,"marketCap":44204738},{"date":"2022-08-26","current":-3.110248,"twenty":-6.585341,"median":-3.798931,"eighty":-2.789652,"marketCap":39064652},{"date":"2022-09-02","current":-3.073871,"twenty":-6.56481,"median":-3.780666,"eighty":-2.792596,"marketCap":38607755},{"date":"2022-09-09","current":-3.965112,"twenty":-6.551978,"median":-3.772829,"eighty":-2.798485,"marketCap":49801720},{"date":"2022-09-16","current":-3.542438,"twenty":-6.531447,"median":-3.78062,"eighty":-2.805846,"marketCap":44492944},{"date":"2022-09-23","current":-2.787945,"twenty":-6.521181,"median":-3.757935,"eighty":-2.805846,"marketCap":35016525},{"date":"2022-09-30","current":-2.760341,"twenty":-6.47242,"median":-3.73516,"eighty":-2.805846,"marketCap":34669827},{"date":"2022-10-07","current":-3.128387,"twenty":-6.436491,"median":-3.71694,"eighty":-2.811734,"marketCap":39292470},{"date":"2022-10-14","current":-2.714336,"twenty":-6.41596,"median":-3.689609,"eighty":-2.811734,"marketCap":34091996},{"date":"2022-10-21","current":-2.806347,"twenty":-6.41596,"median":-3.672742,"eighty":-2.791124,"marketCap":35247657},{"date":"2022-10-28","current":-3.027174,"twenty":-6.413394,"median":-3.653169,"eighty":-2.791124,"marketCap":38021243},{"date":"2022-11-04","current":-2.723537,"twenty":-6.395429,"median":-3.644059,"eighty":-2.783423,"marketCap":34207562},{"date":"2022-11-11","current":-2.94384,"twenty":-6.362066,"median":-3.619529,"eighty":-2.778468,"marketCap":33734492},{"date":"2022-11-18","current":-3.196747,"twenty":-6.346667,"median":-3.595377,"eighty":-2.782292,"marketCap":36632644},{"date":"2022-11-25","current":-2.953956,"twenty":-6.326136,"median":-3.588921,"eighty":-2.782292,"marketCap":33850418},{"date":"2022-12-02","current":-3.338375,"twenty":-6.313304,"median":-3.534737,"eighty":-2.787945,"marketCap":38255609},{"date":"2022-12-09","current":-3.743026,"twenty":-6.300472,"median":-3.538588,"eighty":-2.789652,"marketCap":42892653},{"date":"2022-12-16","current":-3.874538,"twenty":-6.223481,"median":-3.589398,"eighty":-2.789652,"marketCap":44399692},{"date":"2022-12-23","current":-3.975701,"twenty":-6.184985,"median":-3.603063,"eighty":-2.797013,"marketCap":45558953},{"date":"2022-12-30","current":-4.026282,"twenty":-6.174719,"median":-3.62058,"eighty":-2.802902,"marketCap":46138583},{"date":"2023-01-06","current":-4.501748,"twenty":-6.172153,"median":-3.638406,"eighty":-2.805558,"marketCap":51587110},{"date":"2023-01-13","current":-4.299422,"twenty":-6.164454,"median":-3.644059,"eighty":-2.809579,"marketCap":49268588},{"date":"2023-01-20","current":-4.258957,"twenty":-6.159321,"median":-3.653169,"eighty":-2.811734,"marketCap":48804883},{"date":"2023-01-27","current":-3.884654,"twenty":-6.149055,"median":-3.672742,"eighty":-2.8141,"marketCap":44515618},{"date":"2023-02-03","current":-3.540701,"twenty":-6.118259,"median":-3.662279,"eighty":-2.817733,"marketCap":40574131},{"date":"2023-02-10","current":-3.540701,"twenty":-6.069498,"median":-3.644059,"eighty":-2.819825,"marketCap":40574131},{"date":"2023-02-17","current":-3.70246,"twenty":-6.015604,"median":-3.644059,"eighty":-2.823936,"marketCap":42427789},{"date":"2023-02-24","current":-3.287793,"twenty":-5.98994,"median":-3.641863,"eighty":-2.825677,"marketCap":37675979},{"date":"2023-03-03","current":-3.641863,"twenty":-5.979674,"median":-3.638406,"eighty":-2.827332,"marketCap":41733392},{"date":"2023-03-10","current":-3.469887,"twenty":-5.977108,"median":-3.621631,"eighty":-2.83395,"marketCap":39762648},{"date":"2023-03-17","current":-3.021341,"twenty":-5.959143,"median":-3.604508,"eighty":-2.834944,"marketCap":36536396},{"date":"2023-03-24","current":-3.406225,"twenty":-5.925781,"median":-3.592246,"eighty":-2.839484,"marketCap":41190714},{"date":"2023-03-31","current":-3.329248,"twenty":-5.907816,"median":-3.59034,"eighty":-2.843856,"marketCap":40259850},{"date":"2023-04-06","current":-3.396603,"twenty":-5.877019,"median":-3.579746,"eighty":-2.852353,"marketCap":41074356},{"date":"2023-04-14","current":-2.751922,"twenty":-5.800028,"median":-3.550817,"eighty":-2.852353,"marketCap":33278373},{"date":"2023-04-21","current":-2.97323,"twenty":-5.787196,"median":-3.550817,"eighty":-2.848143,"marketCap":35954606},{"date":"2023-04-28","current":-2.866607,"twenty":-5.735868,"median":-3.540701,"eighty":-2.852353,"marketCap":34665231},{"date":"2023-05-05","current":-2.827999,"twenty":-5.710204,"median":-3.534737,"eighty":-2.841732,"marketCap":34198359},{"date":"2023-05-12","current":-3.19477,"twenty":-5.669142,"median":-3.525038,"eighty":-2.846189,"marketCap":38633641},{"date":"2023-05-19","current":-2.850337,"twenty":-5.633213,"median":-3.510352,"eighty":-2.847975,"marketCap":35132102},{"date":"2023-05-26","current":-2.937567,"twenty":-5.611399,"median":-3.474945,"eighty":-2.849898,"marketCap":36207255},{"date":"2023-06-02","current":-2.937567,"twenty":-5.59985,"median":-3.447184,"eighty":-2.851547,"marketCap":36207255},{"date":"2023-06-09","current":-2.808114,"twenty":-5.517726,"median":-3.439538,"eighty":-2.851547,"marketCap":34611681},{"date":"2023-06-16","current":-2.738409,"twenty":-5.4433,"median":-3.429421,"eighty":-2.847807,"marketCap":33752526},{"date":"2023-06-23","current":-2.569126,"twenty":-5.402238,"median":-3.402649,"eighty":-2.838681,"marketCap":31666006},{"date":"2023-06-30","current":-2.68862,"twenty":-5.340645,"median":-3.397344,"eighty":-2.829189,"marketCap":33138844},{"date":"2023-07-07","current":-2.540461,"twenty":-5.248255,"median":-3.388974,"eighty":-2.822775,"marketCap":31312689},{"date":"2023-07-14","current":-2.40399,"twenty":-4.837634,"median":-3.364889,"eighty":-2.811734,"marketCap":29630603},{"date":"2023-07-21","current":-2.361999,"twenty":-4.609734,"median":-3.350513,"eighty":-2.798157,"marketCap":29113038},{"date":"2023-07-28","current":-1.847608,"twenty":-4.542213,"median":-3.33875,"eighty":-2.787945,"marketCap":22772865},{"date":"2023-08-04","current":-2.21503,"twenty":-4.527743,"median":-3.338375,"eighty":-2.777512,"marketCap":27301560},{"date":"2023-08-11","current":-1.900097,"twenty":-4.527743,"median":-3.329248,"eighty":-2.760341,"marketCap":23419821},{"date":"2023-08-18","current":-1.869135,"twenty":-4.501748,"median":-3.318884,"eighty":-2.76021,"marketCap":24579691},{"date":"2023-08-25","current":-2.017479,"twenty":-4.482192,"median":-3.315273,"eighty":-2.741939,"marketCap":26530461},{"date":"2023-09-01","current":-1.908693,"twenty":-4.454861,"median":-3.304204,"eighty":-2.73148,"marketCap":25099897},{"date":"2023-09-08","current":-1.75046,"twenty":-4.432997,"median":-3.297891,"eighty":-2.723392,"marketCap":23019076},{"date":"2023-09-15","current":-1.710901,"twenty":-4.39109,"median":-3.28304,"eighty":-2.713206,"marketCap":22498871},{"date":"2023-09-22","current":-1.582336,"twenty":-4.374692,"median":-3.266474,"eighty":-2.696583,"marketCap":20808204},{"date":"2023-09-29","current":-1.463661,"twenty":-4.343718,"median":-3.252322,"eighty":-2.679128,"marketCap":19247589},{"date":"2023-10-06","current":-1.542778,"twenty":-4.329142,"median":-3.235119,"eighty":-2.671147,"marketCap":20287999},{"date":"2023-10-13","current":-4.034958,"twenty":-4.32732,"median":-3.237569,"eighty":-2.671147,"marketCap":53060922},{"date":"2023-10-20","current":-4.964581,"twenty":-4.374692,"median":-3.256877,"eighty":-2.671883,"marketCap":65285742},{"date":"2023-10-27","current":-4.667893,"twenty":-4.397094,"median":-3.266474,"eighty":-2.673013,"marketCap":61384204},{"date":"2023-11-03","current":-3.758049,"twenty":-4.476726,"median":-3.28304,"eighty":-2.677757,"marketCap":49419486},{"date":"2023-11-10","current":-3.708601,"twenty":-4.449395,"median":-3.283194,"eighty":-2.678778,"marketCap":48769230},{"date":"2023-11-17","current":-3.917109,"twenty":-4.422199,"median":-3.297873,"eighty":-2.680716,"marketCap":49840076},{"date":"2023-11-24","current":-4.187628,"twenty":-4.400873,"median":-3.300382,"eighty":-2.686605,"marketCap":53282070},{"date":"2023-12-01","current":-3.808902,"twenty":-4.38198,"median":-3.312639,"eighty":-2.68862,"marketCap":48463279},{"date":"2023-12-08","current":-4.696202,"twenty":-4.38198,"median":-3.318142,"eighty":-2.693965,"marketCap":59753020},{"date":"2023-12-15","current":-3.63577,"twenty":-4.37287,"median":-3.328111,"eighty":-2.697237,"marketCap":46260402},{"date":"2023-12-22","current":-3.884647,"twenty":-4.343718,"median":-3.333812,"eighty":-2.703555,"marketCap":49427037},{"date":"2023-12-29","current":-4.295835,"twenty":-4.333177,"median":-3.338375,"eighty":-2.706495,"marketCap":54658868},{"date":"2024-01-05","current":-4.285014,"twenty":-4.33643,"median":-3.338563,"eighty":-2.708536,"marketCap":54521188},{"date":"2024-01-12","current":-5.204777,"twenty":-4.400873,"median":-3.348492,"eighty":-2.708686,"marketCap":66223969},{"date":"2024-01-19","current":-4.328297,"twenty":-4.440176,"median":-3.358415,"eighty":-2.713206,"marketCap":55071908},{"date":"2024-01-26","current":-4.317476,"twenty":-4.429326,"median":-3.377159,"eighty":-2.715705,"marketCap":54934228},{"date":"2024-02-02","current":-3.527562,"twenty":-4.406205,"median":-3.396603,"eighty":-2.721877,"marketCap":44883605},{"date":"2024-02-09","current":-3.321968,"twenty":-4.385759,"median":-3.397158,"eighty":-2.723334,"marketCap":42267689},{"date":"2024-02-16","current":-3.300327,"twenty":-4.374692,"median":-3.388974,"eighty":-2.723392,"marketCap":41992329},{"date":"2024-02-23","current":-3.386893,"twenty":-4.359111,"median":-3.386893,"eighty":-2.723485,"marketCap":43093768},{"date":"2024-03-01","current":-3.105553,"twenty":-4.341834,"median":-3.386893,"eighty":-2.727023,"marketCap":39514093},{"date":"2024-03-08","current":-3.213761,"twenty":-4.33155,"median":-3.364889,"eighty":-2.730627,"marketCap":40890891},{"date":"2024-03-15","current":-2.932421,"twenty":-4.328297,"median":-3.350513,"eighty":-2.735016,"marketCap":37311217},{"date":"2024-03-22","current":-2.226653,"twenty":-4.328297,"median":-3.33875,"eighty":-2.723485,"marketCap":32459630},{"date":"2024-03-28","current":-2.518496,"twenty":-4.327906,"median":-3.338375,"eighty":-2.718962,"marketCap":36714047},{"date":"2024-04-05","current":-2.118563,"twenty":-4.32732,"median":-3.329248,"eighty":-2.706495,"marketCap":30883919},{"date":"2024-04-12","current":-2.021282,"twenty":-4.323676,"median":-3.321968,"eighty":-2.687411,"marketCap":29465780},{"date":"2024-04-19","current":-2.302316,"twenty":-4.318209,"median":-3.318884,"eighty":-2.674142,"marketCap":33562627},{"date":"2024-04-26","current":-2.183417,"twenty":-4.318209,"median":-3.315273,"eighty":-2.664523,"marketCap":31829346},{"date":"2024-05-03","current":-2.301105,"twenty":-4.317916,"median":-3.304204,"eighty":-2.652746,"marketCap":33544976},{"date":"2024-05-10","current":-2.192562,"twenty":-4.316324,"median":-3.29791,"eighty":-2.63511,"marketCap":31962666},{"date":"2024-05-17","current":-2.129106,"twenty":-4.308527,"median":-3.285571,"eighty":-2.616729,"marketCap":34177900},{"date":"2024-05-24","current":-2.57267,"twenty":-4.299422,"median":-3.281137,"eighty":-2.577025,"marketCap":41298296},{"date":"2024-05-31","current":-2.477227,"twenty":-4.298705,"median":-3.261432,"eighty":-2.56885,"marketCap":39766186},{"date":"2024-06-07","current":-2.368663,"twenty":-4.295086,"median":-3.249273,"eighty":-2.539607,"marketCap":38023444},{"date":"2024-06-14","current":-2.398272,"twenty":-4.291572,"median":-3.237569,"eighty":-2.530033,"marketCap":38498737},{"date":"2024-06-21","current":-2.299577,"twenty":-4.289508,"median":-3.235402,"eighty":-2.519465,"marketCap":36914427},{"date":"2024-06-28","current":-2.220622,"twenty":-4.285014,"median":-3.234651,"eighty":-2.502591,"marketCap":35646979},{"date":"2024-07-05","current":-2.033103,"twenty":-4.280355,"median":-3.233027,"eighty":-2.482891,"marketCap":32636790},{"date":"2024-07-12","current":-2.279839,"twenty":-4.271096,"median":-3.223405,"eighty":-2.467358,"marketCap":36597565},{"date":"2024-07-19","current":-2.398272,"twenty":-4.264513,"median":-3.212378,"eighty":-2.463479,"marketCap":38498737},{"date":"2024-07-26","current":-2.25023,"twenty":-4.25984,"median":-3.210996,"eighty":-2.445645,"marketCap":36122272},{"date":"2024-08-02","current":-2.08245,"twenty":-4.250864,"median":-3.208522,"eighty":-2.402846,"marketCap":33428945},{"date":"2024-08-09","current":-1.825588,"twenty":-4.246031,"median":-3.202969,"eighty":-2.384084,"marketCap":30540786},{"date":"2024-08-16","current":-1.951826,"twenty":-4.23804,"median":-3.197661,"eighty":-2.361358,"marketCap":32652648},{"date":"2024-08-23","current":-2.204301,"twenty":-4.236218,"median":-3.19477,"eighty":-2.345346,"marketCap":36876374},{"date":"2024-08-30","current":-2.136326,"twenty":-4.223316,"median":-3.188517,"eighty":-2.302074,"marketCap":35739217},{"date":"2024-09-06","current":-1.922694,"twenty":-4.219131,"median":-3.172148,"eighty":-2.286104,"marketCap":32165296},{"date":"2024-09-13","current":-1.980957,"twenty":-4.218492,"median":-3.165041,"eighty":-2.275891,"marketCap":33140001},{"date":"2024-09-20","current":-1.951826,"twenty":-4.21273,"median":-3.15797,"eighty":-2.265537,"marketCap":32652648},{"date":"2024-09-27","current":-1.86443,"twenty":-4.202511,"median":-3.146776,"eighty":-2.257421,"marketCap":31190590},{"date":"2024-10-04","current":-2.087774,"twenty":-4.19188,"median":-3.130117,"eighty":-2.249446,"marketCap":34926962},{"date":"2024-10-11","current":-2.010089,"twenty":-4.187628,"median":-3.128387,"eighty":-2.234788,"marketCap":33627354},{"date":"2024-10-18","current":-1.951826,"twenty":-4.187628,"median":-3.113033,"eighty":-2.220622,"marketCap":32652648},{"date":"2024-10-25","current":-1.786746,"twenty":-4.178519,"median":-3.10794,"eighty":-2.213319,"marketCap":29890982},{"date":"2024-11-01","current":-1.806167,"twenty":-4.166981,"median":-3.100143,"eighty":-2.203947,"marketCap":30215884},{"date":"2024-11-08","current":-1.806167,"twenty":-4.157871,"median":-3.088695,"eighty":-2.19356,"marketCap":30215884},{"date":"2024-11-15","current":-1.767787,"twenty":-4.150298,"median":-3.081142,"eighty":-2.181144,"marketCap":29055182},{"date":"2024-11-22","current":-1.387508,"twenty":-4.135209,"median":-3.07318,"eighty":-2.149641,"marketCap":22804939},{"date":"2024-11-29","current":-1.284729,"twenty":-4.125219,"median":-3.065235,"eighty":-2.140727,"marketCap":21115685},{"date":"2024-12-06","current":-0.770838,"twenty":-4.120736,"median":-3.05063,"eighty":-2.136326,"marketCap":12669411},{"date":"2024-12-13","current":-0.878858,"twenty":-4.111282,"median":-3.042419,"eighty":-2.129883,"marketCap":14444817},{"date":"2024-12-20","current":-0.847921,"twenty":-4.10134,"median":-3.035027,"eighty":-2.112058,"marketCap":13936352},{"date":"2024-12-27","current":-0.918838,"twenty":-4.100763,"median":-3.029808,"eighty":-2.097994,"marketCap":15101937},{"date":"2025-01-03","current":-0.914624,"twenty":-4.099566,"median":-3.026769,"eighty":-2.087774,"marketCap":15032678},{"date":"2025-01-10","current":-0.830655,"twenty":-4.092278,"median":-3.023853,"eighty":-2.081672,"marketCap":13652557},{"date":"2025-01-17","current":-0.907533,"twenty":-4.090284,"median":-3.019134,"eighty":-2.067585,"marketCap":14916119},{"date":"2025-01-24","current":-0.895816,"twenty":-4.090241,"median":-3.010309,"eighty":-2.058642,"marketCap":14723544},{"date":"2025-01-31","current":-0.750899,"twenty":-4.090241,"median":-2.997753,"eighty":-2.043977,"marketCap":12341695},{"date":"2025-02-07","current":-0.795813,"twenty":-4.088284,"median":-2.986227,"eighty":-2.027397,"marketCap":13079899},{"date":"2025-02-14","current":-0.762615,"twenty":-4.072667,"median":-2.973442,"eighty":-2.016716,"marketCap":12534270},{"date":"2025-02-21","current":-0.804343,"twenty":-4.056659,"median":-2.970335,"eighty":-2.010243,"marketCap":13220108},{"date":"2025-02-28","current":-0.729212,"twenty":-4.04696,"median":-2.964072,"eighty":-1.994631,"marketCap":11985262},{"date":"2025-03-07","current":-0.470005,"twenty":-4.046781,"median":-2.953761,"eighty":-1.988678,"marketCap":7724962},{"date":"2025-03-14","current":-0.534112,"twenty":-4.045871,"median":-2.953473,"eighty":-1.982077,"marketCap":8778614},{"date":"2025-03-21","current":-0.661755,"twenty":-4.044905,"median":-2.944364,"eighty":-1.980421,"marketCap":9332799},{"date":"2025-03-28","current":-0.638311,"twenty":-4.041261,"median":-2.937567,"eighty":-1.964134,"marketCap":9002161},{"date":"2025-04-04","current":-0.500145,"twenty":-4.03546,"median":-2.933581,"eighty":-1.951826,"marketCap":7053603},{"date":"2025-04-11","current":-0.553755,"twenty":-4.032484,"median":-2.92512,"eighty":-1.947591,"marketCap":7809661},{"date":"2025-04-17","current":-0.58267,"twenty":-4.028274,"median":-2.922007,"eighty":-1.938558,"marketCap":8217448},{"date":"2025-04-25","current":-0.632371,"twenty":-4.026282,"median":-2.909973,"eighty":-1.922833,"marketCap":8918399},{"date":"2025-05-02","current":-0.645031,"twenty":-4.026089,"median":-2.905875,"eighty":-1.915453,"marketCap":9096944},{"date":"2025-05-09","current":-0.562664,"twenty":-4.023768,"median":-2.898358,"eighty":-1.909551,"marketCap":7935303},{"date":"2025-05-16","current":-0.71839,"twenty":-4.016958,"median":-2.893258,"eighty":-1.899063,"marketCap":8530451},{"date":"2025-05-23","current":-0.73918,"twenty":-4.01329,"median":-2.887777,"eighty":-1.872577,"marketCap":8777327},{"date":"2025-05-30","current":-0.717833,"twenty":-4.008464,"median":-2.885625,"eighty":-1.86443,"marketCap":8523839},{"date":"2025-06-06","current":-0.687081,"twenty":-4.008464,"median":-2.879956,"eighty":-1.85472,"marketCap":8158684},{"date":"2025-06-13","current":-0.652772,"twenty":-4.00605,"median":-2.871746,"eighty":-1.84598,"marketCap":7751278},{"date":"2025-06-20","current":-1.423798,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"marketCap":16906756}],"updateTime":1750726054317}}}